Research output per year
Research output per year
Personal profile
Biography
Dr Reyhaneh is an Assistant Lecturer at Jeffrey Cheah School of Medicine and Health Sciences. She obtained her PhD degree in Molecular Medicine from University of Malaya (UM) in 2019. Her PhD project was awarded for the Postgraduate Research Grant from University of Malaya focusing on molecular and cellular mechanism of action of anti-breast cancer activity of novel Schiff-based compounds as the promising anticancer agents in breast cancer treatment.
Dr Reyhaneh is a scientist with keen interests in anti-cancer drug discovery and development. Her certain unique set of skills, knowledge and experiences has led to several publications in internationally reputed high impact journals. Last but not the least, Dr Reyhaneh's dream is to make a difference in fighting against breast cancer and she is currently working on natural product in breast cancer therapy.
Research interests
Molecular oncology, Cancer drug discovery, Cancer therapy
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Molecular Medicine, Doctor of Philosophy, Universiti Malaya (University of Malaya)
Sep 2015 → Aug 2019
Award Date: 22 Aug 2019
Biotechnology, Master of Science, Universiti Teknologi Malaysia (University of Technology Malaysia)
Jan 2011 → Mar 2013
Award Date: 13 Mar 2013
Cellular & Molecular Biology- Genetics, Bachelor of Science, Shahrekord University
2005 → 2009
Award Date: 18 Aug 2009
Research area keywords
- Cancer therapy
- Apoptosis
- Curcumin
- Breast cancer
- Singnaling pathway
- Cytotoxicity
- Anti-cancer drug screening
- Drug Discovery
- TNBC
- Cell Culture
- Natural products
- Shaghayegh
- Rihanna
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Curcumin as an enhancer of therapeutic efficiency of chemotherapy drugs in breast cancer
Farghadani, R. & Naidu, R., 2 Feb 2022, In: International Journal of Molecular Sciences. 23, 4, 19 p., 2144.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile13 Citations (Scopus) -
Natural quinones induce ROS-mediated apoptosis and inhibit cell migration in PANC-1 human pancreatic cancer cell line
Narayanan, P., Farghadani, R., Nyamathulla, S., Rajarajeswaran, J., Thirugnanasampandan, R. & Bhuwaneswari, G., May 2022, In: Journal of Biochemical and Molecular Toxicology. 36, 5, 12 p., e23008.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
The Role of Apoptosis as a Double-Edge Sword in Cancer
Farghadani, R. & Naidu, R., Apr 2022, Regulation and Dysfunction of Apoptosis. Tutar, Y. (ed.). 1st ed. United Kingdom: IntechOpen Limited, p. 1-22 22 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Research › peer-review
Open AccessFile -
Curcumin: Modulator of key molecular signaling pathways in hormone-independent breast cancer
Farghadani, R. & Naidu, R., 2 Jul 2021, In: Cancers. 13, 14, 29 p., 3427.Research output: Contribution to journal › Review Article › Research › peer-review
Open AccessFile24 Citations (Scopus) -
Receptor tyrosine kinases and their signaling pathways as therapeutic targets of curcumin in cancer
Sudhesh Dev, S., Zainal Abidin, S. A., Farghadani, R., Othman, I. & Naidu, R., 15 Nov 2021, In: Frontiers in Pharmacology. 12, 26 p., 772510.Research output: Contribution to journal › Review Article › Research › peer-review
Open AccessFile13 Citations (Scopus)